-
TD Cowen Starts Damora Therapeutics (DMRA) at Buy
-
RBC Capital Starts Damora Therapeutics (DMRA) at Outperform, $40 PT
-
Evercore ISI Starts Damora Therapeutics (DMRA) at Outperform
-
Damora Therapeutics (DMRA) PT Lowered to $55 at Leerink Partners

